Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 256

1.

Failure of potassium canrenoate to alter experimentally induced digitalis arrhythmias.

Lucchesi BR, Haley NR.

Eur J Pharmacol. 1973 Jun;22(3):256-62. No abstract available.

PMID:
4732564
2.

Use of potassium canrenoate to suppress ouabain-induced ventricular arrhythmias in dogs.

Yeh BK, Sung PK, Saha AK.

Circ Res. 1972 Dec;31(6):915-22. No abstract available.

3.

The specificity of potassium canrenoate, a steroidal antidysrhythmic drug.

Yeh BK, Sung PK, Lazzara R.

Clin Pharmacol Ther. 1974 Dec;16(6):1014-22. No abstract available.

PMID:
4433469
4.

Effect of potassium canrenoate on cardiac functions and (Na + + K + )-activated ATPase.

Baskin SI, Akera T, Puckett CR, Brody SL, Brody TM.

Proc Soc Exp Biol Med. 1973 Jun;143(2):495-8. No abstract available.

PMID:
4267771
6.

Pentazocine: hemodynamic and electrophysiologic properties.

Hayakawa H, Mandel WJ, Vyden JK, Parmley WW, Corday E, McCullen A, Allen D.

J Clin Pharmacol. 1973 Aug-Sep;13(8):313-24. No abstract available.

PMID:
4490007
7.
8.

The effects of disobutamide on electrophysiologic properties of canine cardiac Purkinje fibers and papillary muscle.

Dohrmann ML, Harrell FE Jr, Strauss HC.

J Pharmacol Exp Ther. 1981 Jun;217(3):549-54. No abstract available.

PMID:
7229991
9.

The effect of glucagon on arrhythmias due to digitalis toxicity.

Cohn KE, Agmon J, Gamble OW.

Am J Cardiol. 1970 Jun;25(6):683-9. No abstract available.

PMID:
4192693
10.

The effect of different types of anesthesia on digitalis toxicity.

Stickney JL.

Am Heart J. 1974 Jun;87(6):734-9. No abstract available.

PMID:
4828809
11.

The antiarrhythmic properties of UM-272, the dimethyl quaternary derivative of propranolol.

Schuster DP, Lucchesi BR, Nobel NL, Mimnaugh MN, Counsell RE, Kniffen FJ.

J Pharmacol Exp Ther. 1973 Jan;184(1):213-27. No abstract available.

PMID:
4405548
12.

Effects of hypothermia and pronethalol on ionic correlates of ouabain arrhythmias in dogs.

el-Fiky SB, Katzung BG.

Circ Res. 1969 Jan;24(1):43-50. No abstract available.

13.
14.

Prevention and abolition of ouabain-induced ventricular tachycardia by potassium canrenoate in dogs.

Yeh BK, Sung PK.

Eur J Pharmacol. 1972 Aug;19(2):151-5. No abstract available.

PMID:
5071786
15.

Electropharmacology of potassium canrenoate.

Hollander PB, Marks BH, Little WC.

Proc Soc Exp Biol Med. 1974 Feb;145(2):710-5. No abstract available.

PMID:
4814164
16.

The effect of diphenylthiohydantoin (DPTH) on digitalis-induced cardiac arrhythmia.

Sohn YJ, Raines A, Standaert G, Levitt B.

Arch Int Pharmacodyn Ther. 1969 Jun;179(2):434-41. No abstract available.

PMID:
5367313
17.

[Effect of a spironolactone, potassium canrenoate, on arrhythmia of the isolated auricle induced by a digitalic drug].

Lamarche M, Royer R.

C R Seances Soc Biol Fil. 1971;165(6):1432-3. French. No abstract available.

PMID:
4262058
18.

[Studies on the effect of peruvoside on heart function in animal experiments].

Schorscher E, Sommer S, Wild AJ, Block A.

Arzneimittelforschung. 1968 Dec;18(12):1582-90. German. No abstract available.

PMID:
5756257
19.

Effects of ventricular stimulation and potassium administration on digitalis-induced arrhythmias.

Zelis R, Mason DT, Spann JF Jr, Braunwald E.

Am J Cardiol. 1970 Apr;25(4):428-33. No abstract available.

PMID:
5438237
20.
Items per page

Supplemental Content

Write to the Help Desk